Silence Therapeutics (SLN) Inventory (2022 - 2023)
Silence Therapeutics recorded quarterly Inventory of $483772.8 in Q1 2023, down 7.52% quarter-over-quarter from $523126.0 in Q4 2022.
Silence Therapeutics' Inventory history runs 2 years deep, the most recent figure standing at $483772.8 for Q1 2023.
- In Q1 2023, Inventory changed N/A year-over-year to $483772.8; the TTM figure through Mar 2023 stood at $483772.8 (changed N/A YoY), while the FY2022 annual figure was $551973.7, changed N/A from the prior year.
- Inventory came in at $483772.8 for Q1 2023 at Silence Therapeutics, down from $523126.0 in the prior quarter.
- In the past five years, Inventory ranged from a high of $523126.0 in Q4 2022 to a low of $483772.8 in Q1 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 32.00 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.77 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.10 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 84.03 Mn |
| 10 | Silence Therapeutics | 924.61 Mn | 854.53 Mn | 411,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 483,772.79 |
| Dec 31, 2022 | 523,126.03 |